MRK
Price
$83.66
Change
-$0.27 (-0.32%)
Updated
Oct 17, 12:12 PM (EDT)
Capitalization
209.61B
13 days until earnings call
Intraday Buy/Sell Signals
PFE
Price
$24.28
Change
+$0.05 (+0.21%)
Updated
Oct 17, 12:15 PM (EDT)
Capitalization
137.76B
18 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

MRK vs PFE

Header iconMRK vs PFE Comparison
Open Charts MRK vs PFEBanner chart's image
Merck & Co
Price$83.66
Change-$0.27 (-0.32%)
Volume$6.8K
Capitalization209.61B
Pfizer
Price$24.28
Change+$0.05 (+0.21%)
Volume$104.13K
Capitalization137.76B
MRK vs PFE Comparison Chart in %
MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PFE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MRK vs. PFE commentary
Oct 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRK is a Hold and PFE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 17, 2025
Stock price -- (MRK: $83.92 vs. PFE: $24.23)
Brand notoriety: MRK and PFE are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: MRK: 99% vs. PFE: 87%
Market capitalization -- MRK: $209.61B vs. PFE: $137.76B
MRK [@Pharmaceuticals: Major] is valued at $209.61B. PFE’s [@Pharmaceuticals: Major] market capitalization is $137.76B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $734.54B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $93.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRK’s FA Score shows that 1 FA rating(s) are green whilePFE’s FA Score has 1 green FA rating(s).

  • MRK’s FA Score: 1 green, 4 red.
  • PFE’s FA Score: 1 green, 4 red.
According to our system of comparison, both MRK and PFE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRK’s TA Score shows that 4 TA indicator(s) are bullish while PFE’s TA Score has 3 bullish TA indicator(s).

  • MRK’s TA Score: 4 bullish, 6 bearish.
  • PFE’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, MRK is a better buy in the short-term than PFE.

Price Growth

MRK (@Pharmaceuticals: Major) experienced а -4.09% price change this week, while PFE (@Pharmaceuticals: Major) price change was -4.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.75%. For the same industry, the average monthly price growth was +2.42%, and the average quarterly price growth was +20.08%.

Reported Earning Dates

MRK is expected to report earnings on Oct 30, 2025.

PFE is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+0.75% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRK($210B) has a higher market cap than PFE($138B). MRK (12.93) and PFE (12.82) have similar P/E ratio . PFE YTD gains are higher at: -3.756 vs. MRK (-13.212). MRK has higher annual earnings (EBITDA): 25B vs. PFE (20.2B). MRK has less debt than PFE: MRK (35.4B) vs PFE (60.9B). PFE (63.8B) and MRK (63.6B) have equivalent revenues.
MRKPFEMRK / PFE
Capitalization210B138B152%
EBITDA25B20.2B124%
Gain YTD-13.212-3.756352%
P/E Ratio12.9312.82101%
Revenue63.6B63.8B100%
Total CashN/A13.2B-
Total Debt35.4B60.9B58%
FUNDAMENTALS RATINGS
MRK vs PFE: Fundamental Ratings
MRK
PFE
OUTLOOK RATING
1..100
6073
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
10
Undervalued
PROFIT vs RISK RATING
1..100
76100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5554
P/E GROWTH RATING
1..100
8998
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MRK's Valuation (8) in the Pharmaceuticals Major industry is in the same range as PFE (10). This means that MRK’s stock grew similarly to PFE’s over the last 12 months.

MRK's Profit vs Risk Rating (76) in the Pharmaceuticals Major industry is in the same range as PFE (100). This means that MRK’s stock grew similarly to PFE’s over the last 12 months.

MRK's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as PFE (100). This means that MRK’s stock grew similarly to PFE’s over the last 12 months.

PFE's Price Growth Rating (54) in the Pharmaceuticals Major industry is in the same range as MRK (55). This means that PFE’s stock grew similarly to MRK’s over the last 12 months.

MRK's P/E Growth Rating (89) in the Pharmaceuticals Major industry is in the same range as PFE (98). This means that MRK’s stock grew similarly to PFE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MRKPFE
RSI
ODDS (%)
Bearish Trend 1 day ago
56%
Bearish Trend 1 day ago
50%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
51%
Momentum
ODDS (%)
Bearish Trend 1 day ago
47%
Bearish Trend 1 day ago
60%
MACD
ODDS (%)
Bearish Trend 1 day ago
55%
Bearish Trend 1 day ago
60%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
49%
Bearish Trend 1 day ago
60%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
47%
Bullish Trend 1 day ago
52%
Advances
ODDS (%)
Bullish Trend 17 days ago
49%
Bullish Trend 17 days ago
57%
Declines
ODDS (%)
Bearish Trend 1 day ago
52%
Bearish Trend 1 day ago
60%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
50%
Bearish Trend 1 day ago
51%
Aroon
ODDS (%)
Bearish Trend 1 day ago
48%
Bearish Trend 1 day ago
57%
View a ticker or compare two or three
Interact to see
Advertisement
MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PFE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IBBQ25.69-0.09
-0.34%
Invesco Nasdaq Biotechnology ETF
MGK399.94-1.61
-0.40%
Vanguard Mega Cap Growth ETF
PCN13.12-0.19
-1.43%
PIMCO Corporate & Income Strategy Fund
ETHV56.64-1.71
-2.93%
VanEck Ethereum ETF
MJ36.42-2.45
-6.30%
Amplify Alternative Harvest ETF

MRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRK has been loosely correlated with PFE. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if MRK jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRK
1D Price
Change %
MRK100%
-0.23%
PFE - MRK
65%
Loosely correlated
-0.66%
BIIB - MRK
54%
Loosely correlated
-0.97%
ABBV - MRK
54%
Loosely correlated
+0.29%
AZN - MRK
52%
Loosely correlated
-1.18%
AMGN - MRK
51%
Loosely correlated
-0.51%
More

PFE and

Correlation & Price change

A.I.dvisor indicates that over the last year, PFE has been loosely correlated with BIIB. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if PFE jumps, then BIIB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PFE
1D Price
Change %
PFE100%
-0.66%
BIIB - PFE
60%
Loosely correlated
-0.97%
GSK - PFE
60%
Loosely correlated
-0.02%
NVS - PFE
60%
Loosely correlated
+0.62%
BMY - PFE
57%
Loosely correlated
-0.50%
ABBV - PFE
57%
Loosely correlated
+0.29%
More